Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging / Alvaro D.; Hassan C.; Cardinale V.; Carpino G.; Fabris L.; Gringeri E.; Granata V.; Mutignani M.; Morement H.; Giuliante F.; Guglielmi A.; Ridola L.; Marzioni M.; Grazi G.; Guido M.; Giulio E. D.; Tonini G.; Pantano F.; Venere R.; Bragazzi M. C.; Biancanello F.; Faccioli J.; Giannetti A.; Cintolo M.; Giunta M. D.; Gambato M.; Lasagni A.; Izzo F.; Avallone A.; Banales J.; Rossi M.; Catalano C.; Laghi A.; D'amati G.; Mancino M. G.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - ELETTRONICO. - 52:(2020), pp. 1282-1293. [10.1016/j.dld.2020.06.045]

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging

Grazi G.;
2020

Abstract

Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.
2020
52
1282
1293
Alvaro D.; Hassan C.; Cardinale V.; Carpino G.; Fabris L.; Gringeri E.; Granata V.; Mutignani M.; Morement H.; Giuliante F.; Guglielmi A.; Ridola L.; Marzioni M.; Grazi G.; Guido M.; Giulio E. D.; Tonini G.; Pantano F.; Venere R.; Bragazzi M. C.; Biancanello F.; Faccioli J.; Giannetti A.; Cintolo M.; Giunta M. D.; Gambato M.; Lasagni A.; Izzo F.; Avallone A.; Banales J.; Rossi M.; Catalano C.; Laghi A.; D'amati G.; Mancino M. G.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1590865820303339-main.pdf

Accesso chiuso

Dimensione 1.24 MB
Formato Adobe PDF
1.24 MB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1301219
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 37
social impact